Patents by Inventor Volodymyr KUZMENKO

Volodymyr KUZMENKO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250136927
    Abstract: The invention relates to a composition for preparing a 3D scaffold for culturing cells and tissue, such as human cells and tissue. In particular embodiments, the present invention relates to a composition comprising a biocompatible polymer suitable for the preparation of a hydrogel, and a modified extracellular matrix (ECM) protein that is unreactive towards the biocompatible polymer, such that, after preparation of a hydrogel, the modified ECM protein is not covalently bound to the hydrogel. Compositions of the invention are suitable for use in 3D bioprinting, tissue engineering, drug screening, disease modelling and methods of treatment such as tissue regeneration.
    Type: Application
    Filed: September 13, 2022
    Publication date: May 1, 2025
    Applicants: The University Court of the University of Glasgow, Imperial College Innovations Limited, Cellink Bioprinting AB
    Inventors: Oana DOBRE, Sara TRUJILLO-MUNOZ, Matthew John DALBY, Manuel SALMERON-SANCHEZ, Liliang OUYANG, Molly STEVENS, Adel Itedal Namro REDWAN, Volodymyr KUZMENKO, Erik GATENHOLM, Hector MARTINEZ
  • Publication number: 20240226377
    Abstract: The present invention relates to silk fibroin bioinks specifically formulated for use in 3D bioprinting and the production of ex-vivo models capable of supporting hematopoiesis and the production of platelets and blood cells.
    Type: Application
    Filed: February 24, 2022
    Publication date: July 11, 2024
    Inventors: Alessandra BALDUINI, Christian Andrea DI BUDUO, Pierre-Alexandre LAURENT, Erik GATENHOLM, Hector MARTINEZ, Itedale REDWAN-NAMRO, Volodymyr KUZMENKO
  • Publication number: 20240131220
    Abstract: The present invention relates to silk fibroin bioinks specifically formulated for use in 3D bioprinting and the production of ex-vivo models capable of supporting hematopoiesis and the production of platelets and blood cells.
    Type: Application
    Filed: February 24, 2022
    Publication date: April 25, 2024
    Inventors: Alessandra BALDUINI, Christian Andrea DI BUDUO, Pierre-Alexandre LAURENT, Erik GATENHOLM, Hector MARTINEZ, Itedale REDWAN-NAMRO, Volodymyr KUZMENKO